IL127222A - Sustained release pharmaceutical composition comprising 11-¬4-¬2-ä2-hydroxyethoxy)ethyl¾-1-piperazinyl¾dibenzo ¬b f¾ ¬1,4¾ thiazepine or a pharmaceutically acceptable salt thereof - Google Patents

Sustained release pharmaceutical composition comprising 11-¬4-¬2-ä2-hydroxyethoxy)ethyl¾-1-piperazinyl¾dibenzo ¬b f¾ ¬1,4¾ thiazepine or a pharmaceutically acceptable salt thereof

Info

Publication number
IL127222A
IL127222A IL12722297A IL12722297A IL127222A IL 127222 A IL127222 A IL 127222A IL 12722297 A IL12722297 A IL 12722297A IL 12722297 A IL12722297 A IL 12722297A IL 127222 A IL127222 A IL 127222A
Authority
IL
Israel
Prior art keywords
ethyl3⁄4
thiazepine
hydroxyethoxy
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
IL12722297A
Other languages
English (en)
Other versions
IL127222A0 (en
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10794541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL127222(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL127222A0 publication Critical patent/IL127222A0/xx
Publication of IL127222A publication Critical patent/IL127222A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL12722297A 1996-05-31 1997-05-27 Sustained release pharmaceutical composition comprising 11-¬4-¬2-ä2-hydroxyethoxy)ethyl¾-1-piperazinyl¾dibenzo ¬b f¾ ¬1,4¾ thiazepine or a pharmaceutically acceptable salt thereof IL127222A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611328.7A GB9611328D0 (en) 1996-05-31 1996-05-31 Pharmaceutical compositions
PCT/GB1997/001432 WO1997045124A1 (en) 1996-05-31 1997-05-27 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL127222A0 IL127222A0 (en) 2000-06-01
IL127222A true IL127222A (en) 2001-03-19

Family

ID=10794541

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12722297A IL127222A (en) 1996-05-31 1997-05-27 Sustained release pharmaceutical composition comprising 11-¬4-¬2-ä2-hydroxyethoxy)ethyl¾-1-piperazinyl¾dibenzo ¬b f¾ ¬1,4¾ thiazepine or a pharmaceutically acceptable salt thereof

Country Status (31)

Country Link
EP (1) EP0907364B1 (cs)
JP (5) JP2000511170A (cs)
CN (3) CN1511532A (cs)
AR (1) AR003662A1 (cs)
AT (1) ATE222105T1 (cs)
AU (1) AU727219B2 (cs)
BR (1) BR9709271A (cs)
CA (1) CA2251944C (cs)
CZ (1) CZ293760B6 (cs)
DE (1) DE69714739T2 (cs)
DK (1) DK0907364T3 (cs)
EG (1) EG24118A (cs)
ES (1) ES2182079T3 (cs)
GB (2) GB9611328D0 (cs)
HR (1) HRP970299B1 (cs)
HU (1) HU225152B1 (cs)
ID (1) ID18352A (cs)
IL (1) IL127222A (cs)
MY (1) MY120120A (cs)
NO (1) NO327801B1 (cs)
NZ (1) NZ332198A (cs)
PL (1) PL189887B1 (cs)
PT (1) PT907364E (cs)
RU (1) RU2201754C2 (cs)
SI (1) SI0907364T1 (cs)
SK (1) SK284131B6 (cs)
TR (1) TR199802483T2 (cs)
TW (1) TW550076B (cs)
UA (1) UA50772C2 (cs)
WO (1) WO1997045124A1 (cs)
ZA (1) ZA974735B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0003126D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Method of treatment
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
WO2003039516A1 (en) 2001-11-07 2003-05-15 Fujisawa Pharmaceuticla Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions
EP1976487A2 (en) 2006-01-25 2008-10-08 Astron Research Limited Sustained release dosage form of phenothiazine derivatives containing channelizer
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
PT103884A (pt) * 2006-11-17 2008-05-19 Astrazeneca Ab Composições de libertação prolongada e métodos para a sua preparação
ATE480227T1 (de) 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
WO2008110337A2 (en) 2007-03-09 2008-09-18 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
EA018638B1 (ru) * 2008-08-01 2013-09-30 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина
EP2153834A3 (en) 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
WO2010082220A2 (en) * 2009-01-05 2010-07-22 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
TWI478733B (zh) * 2009-05-13 2015-04-01 Wyeth Llc 突釋藥物釋放組合物
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
CN102218042A (zh) * 2011-05-26 2011-10-19 青岛黄海制药有限责任公司 富马酸喹硫平组合物的缓释片剂及其制备方法
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
CN102406606B (zh) * 2011-11-29 2013-01-23 海南美大制药有限公司 富马酸喹硫平脂质体固体制剂
SI2822541T1 (sl) 2012-09-10 2018-12-31 Pharmathen S.A. Farmacevtski sestavek, ki obsega atipično antipsihotično sredstvo, in postopek za njegovo pripravo
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
EP3310344A1 (en) * 2015-06-19 2018-04-25 Biotie Therapies, Inc. Controlled-release tozadenant formulations
CN106187873B (zh) * 2016-07-25 2019-11-05 宜春学院 一种芳胺基烷基氧类化合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3776269D1 (de) * 1986-11-03 1992-03-05 Schering Corp Labetalol tablette mit verzoegerter wirkstoffabgabe.
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
JP3116970B2 (ja) * 1991-06-12 2000-12-11 三菱東京製薬株式会社 ペミロラストカリウムの徐放性製剤
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake

Also Published As

Publication number Publication date
JP2000511170A (ja) 2000-08-29
HRP970299A2 (en) 1998-04-30
SK163998A3 (en) 1999-05-07
PT907364E (pt) 2002-12-31
WO1997045124A1 (en) 1997-12-04
NO985539L (no) 1998-11-27
SI0907364T1 (en) 2003-02-28
EG24118A (en) 2008-07-06
CZ388098A3 (cs) 1999-02-17
AU727219B2 (en) 2000-12-07
NZ332198A (en) 2000-05-26
ES2182079T3 (es) 2003-03-01
GB9611328D0 (en) 1996-08-07
AU2967597A (en) 1998-01-05
DE69714739T2 (de) 2003-05-15
ZA974735B (en) 1997-12-01
PL189887B1 (pl) 2005-10-31
ID18352A (id) 1998-04-02
IL127222A0 (en) 2000-06-01
NO985539D0 (no) 1998-11-27
MY120120A (en) 2005-09-30
DK0907364T3 (da) 2002-11-11
DE69714739D1 (de) 2002-09-19
JP2012031206A (ja) 2012-02-16
HRP970299B1 (en) 2001-12-31
ATE222105T1 (de) 2002-08-15
CA2251944A1 (en) 1997-12-04
JP5888549B2 (ja) 2016-03-22
RU2201754C2 (ru) 2003-04-10
PL330223A1 (en) 1999-05-10
NO327801B1 (no) 2009-09-28
CN1219879A (zh) 1999-06-16
UA50772C2 (uk) 2002-11-15
TR199802483T2 (xx) 1999-02-22
CN1142780C (zh) 2004-03-24
JP2006152006A (ja) 2006-06-15
CN101006985A (zh) 2007-08-01
HUP9902194A2 (hu) 2000-02-28
HUP9902194A3 (en) 2000-03-28
EP0907364B1 (en) 2002-08-14
BR9709271A (pt) 1999-08-10
GB9709761D0 (en) 1997-07-09
CZ293760B6 (cs) 2004-07-14
CA2251944C (en) 2007-04-10
JP2007119495A (ja) 2007-05-17
EP0907364A1 (en) 1999-04-14
JP2014167026A (ja) 2014-09-11
CN1511532A (zh) 2004-07-14
AR003662A1 (es) 1998-09-09
HU225152B1 (en) 2006-07-28
TW550076B (en) 2003-09-01
SK284131B6 (sk) 2004-09-08

Similar Documents

Publication Publication Date Title
IL127222A (en) Sustained release pharmaceutical composition comprising 11-¬4-¬2-ä2-hydroxyethoxy)ethyl¾-1-piperazinyl¾dibenzo ¬b f¾ ¬1,4¾ thiazepine or a pharmaceutically acceptable salt thereof
EP1043030A4 (en) MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
EP0682945A3 (de) Orale Retard-Präparation.
HUP0001494A3 (en) 3-phenoxy-, 3-dibenzo[a,d]cycloheptenyloxy-, 3-dibenz[b,f][1,4]oxazepinyloxy-1-amino-2-propanol derivatives and pharmaceutical compositions containing them
IL136827A0 (en) Oral pharmaceutical extended release dosage form
AP9801255A0 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromyci N a derivatives
SI1064942T1 (en) Sustained release preparation of a macrolide
HUP0103883A3 (en) New sustained release oral formulations
IL147802A0 (en) Sustained release formulation of a peptide
HUP9801256A3 (en) 5'-deoxy-cytidine derivatives, preparation and use thereof and pharmaceutical compositions
IL139775A0 (en) A substituted triazolo-pyridazine derivative and pharmaceutical compositions made therefrom
IL125743A0 (en) A medicinal preparation
IL123525A0 (en) Rapamycin formulations for oral administration
HUP9904345A3 (en) Oral contraceptive
GB9604736D0 (en) A pharmaceutical preparation
ZA982073B (en) Pharmaceutical preparation
HUP0003341A3 (en) Rapamycin formulations for oral administration
IL124356A0 (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
ZA200110453B (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition.
EP0721784A4 (en) SLOW RELEASE DRUG PREPARATION
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
HUP0004132A3 (en) Rapidly soluble drug composition
AU8885298A (en) Sustained-release oral preparation
ZA9811651B (en) 1,2,4-Benzothiadiazine derivatives their preparation and use
ZA986328B (en) Medicaments comprising A 2-(1,2,3,4-tetrahydroxybutyl) parazine derivative novel derivatives and their preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired